Ritanserin, a Selective 5-HT2/1C Antagonist, and Negative Symptoms in Schizophrenia
- 1 October 1993
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 163 (4), 451-455
- https://doi.org/10.1192/bjp.163.4.451
Abstract
The effectiveness of ritanserin, a selective 5-HT2 and 5-HT1c antagonist, in reducing negative symptoms in schizophrenia was investigated in a double-blind, placebo-controlled trial. Trial treatment was added to a stable neuroleptic treatment in 33 schizophrenic patients with predominantly negative symptoms. Ritanserin reduced the negative symptoms, as measured with the SANS. The main reduction was for the items facial expression, global affective flattening, and relationships with friends and peers. Also a reduction in total BPRS score was found, which approached statistical significance. Significant reductions were observed for the BPRS items emotional withdrawal and depressive mood. Ritanserin or other drugs blocking 5-HT2 and/or 5-HT1c receptors could be important in reducing specific symptoms in schizophrenic patients.Keywords
This publication has 21 references indexed in Scilit:
- The Distinction of Positive and Negative SymptomsThe British Journal of Psychiatry, 1991
- 5-HT2 Antagonist Ritanserin in Neuroleptic-Induced ParkinsonismClinical Neuropharmacology, 1990
- The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.Proceedings of the National Academy of Sciences, 1990
- Pharmacology, Function and Adaptive Regulation of 5HT-1c ReceptorsPublished by Springer Nature ,1990
- Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin‐S2 receptor blockerDrug Development Research, 1986
- Dopamine receptors, neuroleptics, and schizophreniaAmerican Journal of Psychiatry, 1981
- MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIAThe Lancet, 1978
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975
- Part III. Speculations on the Processes That Underlie Schizophrenic Symptoms and SignsSchizophrenia Bulletin, 1974
- The Brief Psychiatric Rating ScalePsychological Reports, 1962